Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer
Condition(s):Metastatic Castration-resistant Prostate CancerLast Updated:July 21, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Metastatic Castration-resistant Prostate CancerLast Updated:July 21, 2017Completed
Condition(s):COVID-19 PneumoniaLast Updated:September 1, 2020Unknown status
Condition(s):Metastatic Prostate Cancer; Metastatic Castration-resistant Prostate CancerLast Updated:March 5, 2024Active, not recruiting
Condition(s):Asthma; Reactive Airway DiseaseLast Updated:January 7, 2016Completed
Condition(s):Thyroid DiseasesLast Updated:June 29, 2021Unknown status
Condition(s):Purpura, Thrombocytopenic, IdiopathicLast Updated:June 9, 2017Completed
Condition(s):Prostate CancerLast Updated:April 8, 2021Completed
Condition(s):Bell´s PalsyLast Updated:November 20, 2007Completed
Condition(s):Treatment-naïve; Peripheral T Cell LymphomaLast Updated:March 7, 2024Terminated
Condition(s):Prostate CancerLast Updated:February 1, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.